Pages

Saturday, December 1, 2012

Experimental treatment for PTSD: Ecstasy

Experimental treatment for PTSD: Ecstasy
By Caleb Hellerman
CNN
December 1, 2012

STORY HIGHLIGHTS
Rachel Hope suffered from post-traumatic stress disorder for years
In 2005, she investigated an experimental new treatment: Ecstasy
Dr. Michael Mithoefer convinced the DEA to green-light a study of the treatment
More than 7 million Americans suffer from PTSD

Editor's note: This is the first installment of a three-day series on the controversial use of the drug Ecstasy to treat post-traumatic stress disorder. On Sunday, read more about Rachel Hope's story and the history of MDMA, also known as Ecstasy. And don't miss "Sanjay Gupta MD" at 4:30 p.m. ET Saturday and 7:30 a.m. ET Sunday.


(CNN) -- Rachel Hope was 33 years old when she received a painful reminder: She couldn't outrun the past.

Hope was trying to help a new assistant at her Maui rental property business, but it wasn't going smoothly. Part of it was Hope herself.

"I had this startle reflex," she explained. "The phone would ring, and I'm literally three feet off the floor, screaming.

"My new assistant said, 'You're driving me crazy!' And I would say, 'I'm really sorry, just please try to ignore it. It's embarrassing, but let's keep working.' "

But the young man, a teacher on break, wasn't pushed off easily. Soon after, Hope said, "he walked over to my desk and dropped a stack of papers two inches thick. It was every single PTSD study that was online, and he just said, 'pick one.' "
read more here



Australian veterans talk about benefits of Ecstasy

While there are many more reports on this blog about using Ecstasy to help with PTSD, the research goes back to 2007. Here are a few of them.

Israel tests Ecstasy on war trauma victims April 26, 2008

A New Look At Ecstasy To Treat PTSD February 11, 2008

Ecstasy Trials Was it a fluke -- or the future? November, 22, 2007

No comments:

Post a Comment

If it is not helpful, do not be hurtful. Spam removed so do not try putting up free ad.